Both of IFN-α and IFN-β could contribute to systemic lupus erythematosus (SLE) pathogenesis, and blockade of IFNAR provides effective therapy for systemic autoimmune disease [96]. The gene discussed is IFNAR1; the disease is systemic lupus erythematosus.